clot elastic modulus cem (Hemodyne Inc)
90
Structured Review
Hemodyne Inc
clot elastic modulus cem
Clot Elastic Modulus Cem, supplied by Hemodyne Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/clot+elastic+modulus/clot+elastic+modulus+cem/pmc05349316-152-11-27
Average 90 stars, based on 1 article reviews
Clot Elastic Modulus Cem, supplied by Hemodyne Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/clot+elastic+modulus/clot+elastic+modulus+cem/pmc05349316-152-11-27
Average 90 stars, based on 1 article reviews
clot elastic modulus cem - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Ex Vivo:Article Title: Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients. Article Snippet: NN1731 is a novel variant of recombinant factor VIIa (rFVIIa) that binds to activated platelets, but has greater enzymatic activity than rFVIIa in generating FXa and thrombin.. The effect of NN1731 on clot structure and platelet function was characterized ex vivo in whole blood from healthy volunteers and haemophilic patients.. Blood samples from six healthy volunteers, nine haemophilia A patients with and without inhibitors and one acquired haemophilia A patient, were spiked with increasing concentrations (0.32, 0.64 and 1.28 lg mL) of rFVIIa and NN1731. Coagulation:Article Title: Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients. Article Snippet: NN1731 is a novel variant of recombinant factor VIIa (rFVIIa) that binds to activated platelets, but has greater enzymatic activity than rFVIIa in generating FXa and thrombin.. The effect of NN1731 on clot structure and platelet function was characterized ex vivo in whole blood from healthy volunteers and haemophilic patients.. Blood samples from six healthy volunteers, nine haemophilia A patients with and without inhibitors and one acquired haemophilia A patient, were spiked with increasing concentrations (0.32, 0.64 and 1.28 lg mL) of rFVIIa and NN1731. |